Latest Articles
Gnrh Agonists And Antagonists Drugs For Endometriosis Market - openPR
Gnrh Agonists And Antagonists Drugs For Endometriosis Market openPR
Published: Oct. 22, 2024, 7:03 a.m.
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer - Physician's Weekly
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer Physician's Weekly
Published: Oct. 22, 2024, 6:31 a.m.
GEM Hospital launches Endometriosis Centre in Coimbatore - Medical Buyer
GEM Hospital launches Endometriosis Centre in Coimbatore Medical Buyer
Published: Oct. 22, 2024, 6:14 a.m.
Could sitting in a diver’s tank treat endometriosis? - PressReader
Could sitting in a diver’s tank treat endometriosis? PressReader
Published: Oct. 22, 2024, 4:51 a.m.
A nomogram model to predict recurrence of early-onset endometrial cancer after resection based on clinical parameters and immunohistochemical markers: A multi-institutional study - Frontiers
A nomogram model to predict recurrence of early-onset endometrial cancer after resection based on clinical parameters and immunohistochemical markers: A multi-institutional study Frontiers
Published: Oct. 21, 2024, 6:48 p.m.
Pembrolizumab aids survival with high-risk endometrial cancer - Medical Xpress
Pembrolizumab aids survival with high-risk endometrial cancer Medical Xpress
Published: Oct. 21, 2024, 5:50 p.m.
Markman’s Take: Vibostolimab in dMMR Endometrial Cancer, Adjuvant Chemo in Cervical Cancer, and More - OncLive
Markman’s Take: Vibostolimab in dMMR Endometrial Cancer, Adjuvant Chemo in Cervical Cancer, and More OncLive
Published: Oct. 21, 2024, 5:04 p.m.
New hope for endometriosis: The revolutionary treatment scientists think might help sufferers - without medication - Daily Mail
New hope for endometriosis: The revolutionary treatment scientists think might help sufferers - without medication Daily Mail
Published: Oct. 21, 2024, 3:59 p.m.
Silent struggle as women endure pain, costs of Endometriosis - The Standard
Silent struggle as women endure pain, costs of Endometriosis The Standard
Published: Oct. 21, 2024, 3:36 p.m.
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer - HealthDay
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer HealthDay
Published: Oct. 21, 2024, 3:35 p.m.
Link copied to clipboard!